Literature DB >> 25402596

Visual selective attention is impaired in children prenatally exposed to opioid agonist medication.

Carolien Konijnenberg1, Annika Melinder.   

Abstract

AIMS: To examine whether prenatal exposure to opioid agonist medication is associated with visual selective attention and general attention problems in early childhood.
METHOD: Twenty-two children (mean age = 52.17 months, SD = 1.81) prenatally exposed to methadone, 9 children (mean age = 52.41 months, SD = 1.42) prenatally exposed to buprenorphine and 25 nonexposed comparison children (mean age = 51.44 months, SD = 1.31) were tested. Visual selective attention was measured with a Tobii 1750 Eye Tracker using a spatial negative priming paradigm. Attention problems were measured using the Child Behavior Checklist.
RESULTS: The comparison group demonstrated a larger spatial negative priming effect (mean = 23.50, SD = 45.50) than the exposed group [mean = -6.84, SD = 86.39, F(1,50) = 5.91, p = 0.019, η(2) = 0.11]. No difference in reported attention problems was found [F(1,51) = 1.63, p = 0.21, η(2) = 0.03]. Neonatal abstinence syndrome and prenatal exposure to marijuana were found to predict slower saccade latencies in the exposed group (b = 54.55, SE = 23.56, p = 0.03 and b = 88.86, SE = 32.07, p = 0.01, respectively).
CONCLUSION: Although exposed children did not appear to have attention deficits in daily life, lower performance on the SNP task indicates subtle alteration in the attention system.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25402596     DOI: 10.1159/000366018

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  10 in total

Review 1.  Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.

Authors:  T Lewis; J Dinh; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2015-07-22       Impact factor: 6.875

Review 2.  Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities.

Authors:  Elisabeth Conradt; Tess Flannery; Judy L Aschner; Robert D Annett; Lisa A Croen; Cristiane S Duarte; Alexander M Friedman; Constance Guille; Monique M Hedderson; Julie A Hofheimer; Miranda R Jones; Christine Ladd-Acosta; Monica McGrath; Angela Moreland; Jenae M Neiderhiser; Ruby H N Nguyen; Jonathan Posner; Judith L Ross; David A Savitz; Steven J Ondersma; Barry M Lester
Journal:  Pediatrics       Date:  2019-09       Impact factor: 9.703

3.  Prenatal methadone exposure is associated with altered neonatal brain development.

Authors:  Victoria J Monnelly; Devasuda Anblagan; Alan Quigley; Manuel Blesa Cabez; E Sarah Cooper; Helen Mactier; Scott I Semple; Mark E Bastin; James P Boardman
Journal:  Neuroimage Clin       Date:  2017-12-24       Impact factor: 4.881

Review 4.  Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.

Authors:  Stacey L Klaman; Krystyna Isaacs; Anne Leopold; Joseph Perpich; Susan Hayashi; Jeff Vender; Melinda Campopiano; Hendrée E Jones
Journal:  J Addict Med       Date:  2017 May/Jun       Impact factor: 3.702

Review 5.  Early life stress and environmental influences on the neurodevelopment of children with prenatal opioid exposure.

Authors:  Elisabeth Conradt; Sheila E Crowell; Barry M Lester
Journal:  Neurobiol Stress       Date:  2018-08-15

6.  Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis.

Authors:  Victoria J Monnelly; Ruth Hamilton; Francesca M Chappell; Helen Mactier; James P Boardman
Journal:  Dev Med Child Neurol       Date:  2018-12-03       Impact factor: 5.449

7.  Behavior and Attention Problems in Eight-Year-Old Children with Prenatal Opiate and Poly-Substance Exposure: A Longitudinal Study.

Authors:  Egil Nygaard; Kari Slinning; Vibeke Moe; Kristine B Walhovd
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

Review 8.  Methodological Issues in Assessing the Impact of Prenatal Drug Exposure.

Authors:  Carolien Konijnenberg
Journal:  Subst Abuse       Date:  2015-11-08

Review 9.  Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.

Authors:  Barbara K Zedler; Ashley L Mann; Mimi M Kim; Halle R Amick; Andrew R Joyce; E Lenn Murrelle; Hendrée E Jones
Journal:  Addiction       Date:  2016-06-30       Impact factor: 6.526

10.  Mental health and use of health care services in opioid-exposed school-aged children compared to foster children.

Authors:  Monica Sarfi; Marie Eikemo; Gabrielle K Welle-Strand; Ashley Elizabeth Muller; Stine Lehmann
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-02-16       Impact factor: 4.785

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.